Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

27.75INR
14 Dec 2018
Change (% chg)

Rs-0.45 (-1.60%)
Prev Close
Rs28.20
Open
Rs28.15
Day's High
Rs28.15
Day's Low
Rs27.55
Volume
955,799
Avg. Vol
2,612,086
52-wk High
Rs50.35
52-wk Low
Rs23.55

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 15 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2 2,320.50 2,393.00 2,248.00 --
Year Ending Mar-18 1 9,520.00 9,520.00 9,520.00 --
Year Ending Mar-19 1 10,893.00 10,893.00 10,893.00 11,892.50
Earnings (per share)
Year Ending Mar-18 1 1.30 1.30 1.30 --

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 2,990.00 2,690.41 299.59 10.02
Quarter Ending Jun-18 2,390.00 2,352.53 37.47 1.57
Quarter Ending Mar-18 2,320.50 1,993.17 327.33 14.11
Quarter Ending Dec-17 2,758.00 2,188.22 569.78 20.66
Quarter Ending Sep-17 2,245.50 2,738.09 492.59 21.94

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2,320.50 -- -- -- --
Year Ending Mar-18 9,520.00 -- -- -- --
Year Ending Mar-19 10,893.00 10,893.00 10,893.00 10,893.00 11,892.50

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 -- -- -- --
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 0
Earnings